More

    GSK sells worldwide rights for linerixibat to Alfasigma for $300m



    [
    GSK sells worldwide rights for linerixibat to Alfasigma for $300m
    [og_img]
    https://www.investing.com/news/stock-market-news/gsk-sells-worldwide-rights-for-linerixibat-to-alfasigma-for-300m-93CH-4548764


    Investing.com

    Latest articles

    spot_imgspot_img

    Related articles

    Leave a reply

    Please enter your comment!
    Please enter your name here

    spot_imgspot_img